Lv6
2270 积分 2024-02-19 加入
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
16天前
已完结
Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis
21天前
已完结
Glucagon's Metabolic Action in Health and Disease
1个月前
已完结
Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide
1个月前
已完结
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction
1个月前
已完结
EDG-7500, A First-in-Class Cardiac Sarcomere Modulator, Demonstrates Favorable Tolerability, Safety, And Pharmacokinetics In Healthy Adults
1个月前
已完结
Aficamten reduces cardiac contractility by modifying the actomyosin interaction
2个月前
已完结
The Heart Failure Knights
2个月前
已完结
Aficamten—A Second in Class Cardiac Myosin Inhibitor for Hypertrophic Cardiomyopathy
2个月前
已完结
Two cardiac myosin inhibitors in the treatment of obstructive hypertrophic cardiomyopathy
2个月前
已完结
皖公网安备34019202002308
